Login / Signup

Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.

Divya RanaAllison R McLeodPiyamas K GastonDavid M HillMassroor Pourcyrous
Published in: The Annals of pharmacotherapy (2022)
Buprenorphine and norbuprenorphine UCT concentrations can allow for quantification of in utero fetal exposure and demonstrate an association with a longer duration of exposure with the severity and treatment of NOWS in exposed infants.
Keyphrases
  • umbilical cord
  • mesenchymal stem cells
  • chronic pain
  • pain management
  • birth weight
  • pregnant women
  • combination therapy